Erratum: Pharmacokinetic changes induced by focused ultrasound in glioma-bearing rats as measured by dynamic contrast-enhanced MRI (PLoS ONE (2014) 9, 3, (e92910) DOI:10.1371/journal.pone.0092910);Pharmacokinetic changes induced by focused ultrasound in glioma-bearing rats as measured by dynamic contrast-enhanced MRI

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Yang, Feng Yi ^a   Ko, Chia En ^a   Huang, Sheng Yao ^a   Chung, I Fang ^a   Chen, Gin Shin ^b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE; CONTRAST MEDIUM; EVANS BLUE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG ACCUMULATION; ERYTHROCYTE; EXTRAVASATION; GLIOMA; HIGH INTENSITY FOCUSED ULTRASOUND; HISTOPATHOLOGY; IMAGE ANALYSIS; KINETICS; MEMBRANE PERMEABILITY; MIDDLE CEREBRAL ARTERY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; ULTRASOUND; ANIMAL; BRAIN TUMOR; CONTRAST MEDIUM EXTRAVASATION; ECHOGRAPHY; FISCHER 344 RAT; MALE; METABOLISM; PATHOLOGY;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; CONTRAST MEDIA; EVANS BLUE; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; GADOLINIUM DTPA; GLIOMA; MAGNETIC RESONANCE IMAGING; MALE; RATS, INBRED F344; SONICATION; ULTRASONICS;

EID: 84899797912     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106782     Document Type: Erratum

References (31)

1. Kroll RA, Neuwelt EA (1998) Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. Neurosurgery 42: 1083-1099; discussion 1099-1100.
2. Neuwelt EA, Abbott NJ, Drewes L, Smith QR, Couraud PO, et al. (1999) Cerebrovascular Biology and the various neural barriers: challenges and future directions. Neurosurgery 44: 604-608; discussion 608-609.
3. Black KL, Ningaraj NS (2004) Modulation of brain tumor capillaries for enhanced drug delivery selectively to brain tumor. Cancer Control 11: 165-173. (Pubitemid 38758221)
4. Hynynen K (2008) Ultrasound for drug and gene delivery to the brain. Adv Drug Deliv Rev 60: 1209-1217.
5. Liu Y, Miyoshi H, Nakamura M (2006) Encapsulated ultrasound microbubbles: therapeutic application in drug/gene delivery. J Control Release 114: 89-99. (Pubitemid 44128627)
6. Yang FY, Teng MC, Lu M, Liang HF, Lee YR, et al. (2012) Treating glioblastoma multiforme with selective high-dose liposomal doxorubicin chemotherapy induced by repeated focused ultrasound. Int J Nanomedicine 7: 965-974.
7. Yang FY, Wang HE, Lin GL, Lin HH, Wong TT (2012) Evaluation of the increase in permeability of the blood-brain barrier during tumor progression after pulsed focused ultrasound. Int J Nanomedicine 7: 723-730.
8. Yang FY, Wong TT, Teng MC, Liu RS, Lu M, et al. (2012) Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme. J Control Release 160: 652-658.
9. Yang FY, Lin YS, Kang KH, Chao TK (2011) Reversible blood-brain barrier disruption by repeated transcranial focused ultrasound allows enhanced extravasation. J Control Release 150: 111-116.
10. Yang FY, Chen CC, Kao YH, Chen CL, Ko CE, et al. (2013) Evaluation of dose distribution of molecular delivery after blood-brain barrier disruption by focused ultrasound with treatment planning. Ultrasound Med Biol 39: 620-627.
11. Su MY, Wang Z, Roth GM, Lao X, Samoszuk MK, et al. (1996) Pharmacokinetic changes induced by vasomodulators in kidneys, livers, muscles, and implanted tumors in rats as measured by dynamic Gd-DTPA-enhanced MRI. Magn Reson Med 36: 868-877. (Pubitemid 26396814)
12. Su MY, Muhler A, Lao X, Nalcioglu O (1998) Tumor characterization with dynamic contrast-enhanced MRI using MR contrast agents of various molecular weights. Magn Reson Med 39: 259-269. (Pubitemid 28099144)
13. Goldstein EJ, Burnett KR, Hansell JR, Casaia J, Dizon J, et al. (1984) Gadolinium DTPA (an NMR proton imaging contrast agent): chemical structure, paramagnetic properties and pharmacokinetics. Physiol Chem Phys Med NMR 16: 97-104.
14. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, et al. (1999) Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10: 223-232. (Pubitemid 29463104)
15. Choi JJ, Pernot M, Brown TR, Small SA, Konofagou EE (2007) Spatio-temporal analysis of molecular delivery through the blood-brain barrier using focused ultrasound. Phys Med Biol 52: 5509-5530. (Pubitemid 350056681)
16. Yang FY, Horng SC, Lin YS, Kao YH (2010) Association between contrast-enhanced MR images and blood-brain barrier disruption following transcranial focused ultrasound. J Magn Reson Imaging 32: 593-599.
17. Hynynen K, McDannold N, Vykhodtseva N, Jolesz FA (2001) Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology 220: 640-646. (Pubitemid 32799969)
18. Yang FY, Wang HE, Lin GL, Teng MC, Lin HH, et al. (2011) Micro-SPECT/CT-based pharmacokinetic analysis of 99mTc- diethylenetriaminepentaacetic acid in rats with blood-brain barrier disruption induced by focused ultrasound. J Nucl Med 52: 478-484.
19. Yang FY, Wang HE, Liu RS, Teng MC, Li JJ, et al. (2012) Pharmacokinetic analysis of 111 in-labeled liposomal Doxorubicin in murine glioblastoma after blood-brain barrier disruption by focused ultrasound. PLoS One 7: e45468.
20. Tartis MS, Kruse DE, Zheng H, Zhang H, Kheirolomoom A, et al. (2008) Dynamic microPET imaging of ultrasound contrast agents and lipid delivery. J Control Release 131: 160-166.
21. Hsieh CH, Chen YF, Chen FD, Hwang JJ, Chen JC, et al. (2005) Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption. J Nucl Med 46: 1858-1865. (Pubitemid 46196648)
22. Park J, Zhang Y, Vykhodtseva N, Jolesz FA, McDannold NJ (2012) The kinetics of blood brain barrier permeability and targeted doxorubicin delivery into brain induced by focused ultrasound. J Control Release 162: 134-142.
23. Vlachos F, Tung YS, Konofagou EE (2010) Permeability assessment of the focused ultrasound-induced blood-brain barrier opening using dynamic contrast-enhanced MRI. Phys Med Biol 55: 5451-5466.
24. Vlachos F, Tung YS, Konofagou E (2011) Permeability dependence study of the focused ultrasound-induced blood-brain barrier opening at distinct pressures and microbubble diameters using DCE-MRI. Magn Reson Med 66: 821-830.
25. Tofts PS, Kermode AG (1991) Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 17: 357-367.
26. Marty B, Larrat B, Van Landeghem M, Robic C, Robert P, et al. (2012) Dynamic study of blood-brain barrier closure after its disruption using ultrasound: a quantitative analysis. J Cereb Blood Flow Metab 32: 1948-1958.
27. Yang FY, Lin GL, Horng SC, Chang TK, Wu SY, et al. (2011) Pulsed high-intensity focused ultrasound enhances the relative permeability of the bloodtumor barrier in a glioma-bearing rat model. IEEE Trans Ultrason Ferroelectr Freq Control 58: 964-970.
28. Peruzzo D, Bertoldo A, Zanderigo F, Cobelli C (2011) Automatic selection of arterial input function on dynamic contrast-enhanced MR images. Comput Methods Prog Biomed 104: e148-e157.
29. Thomas DL, Lythgoe MF, Gadian DG, Ordidge RJ (2006) In vivo measurement of the longitudinal relaxation time of arterial blood (T1a) in the mouse using a pulsed arterial spin labeling approach. Magn Reson Med 55: 943-947.
30. Bilgen M, Narayana PA (2001) A pharmacokinetic model for quantitative evaluation of spinal cord injury with dynamic contrast-enhanced magnetic resonance imaging. Magn Reson Med 46: 1099-1106. (Pubitemid 33104298)
31. Simpson NE, Evelhoch JL (1999) Deuterium NMR tissue perfusion measurements using the tracer uptake approach: II. Comparison with microspheres in tumors. Magn Reson Med 42: 240-247. (Pubitemid 29364702)